InvestEU: EIB agrees €18 million loan to Estonian biotech Icosagen for innovative R&D technologies and new production facility
Kort samengevat
The Estonian biopharmaceutical company Icosagen AS has reached a €18 million financing agreement with the European Investment Bank (EIB) — backed by the InvestEU programme — to further strengthen its drug discovery, development and production services. The funds are part of Icosagen
Verder lezen bij de bron
Bekijk het volledige nieuwsbericht rechtstreeks bij Eureporter.
Lees het volledige bericht ↗